{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:31:29Z","timestamp":1778254289083,"version":"3.51.4"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005198","name":"Chinese Foundation for Hepatitis Prevention and Control","doi-asserted-by":"publisher","award":["TQGB20140083"],"award-info":[{"award-number":["TQGB20140083"]}],"id":[{"id":"10.13039\/501100005198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Science and Technology Department","doi-asserted-by":"publisher","award":["2013B021800290, 2014A020212118,2017A020215015"],"award-info":[{"award-number":["2013B021800290, 2014A020212118,2017A020215015"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870404, 81670518, 81170392"],"award-info":[{"award-number":["81870404, 81670518, 81170392"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> The clinical burden and natural history of non-alcoholic fatty liver disease (NAFLD) vary globally. We aimed to investigate NAFLD-related mortality profiles in hospitalized patients in southern China.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A multicenter retrospective investigation with a 10-year study period (2009\u20132018) analyzed 10,071 deaths during hospitalization (NAFLD: 2,015; other liver diseases: 1,140; without liver diseases: 6,916) was performed using a multiple cause of death analysis. Medical histories and biochemistry and imaging findings were extracted from the electronic medical record system. The underlying causes of death were classified by 10th Revision of the International Classification of Diseases (ICD-10) codes.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The distribution of death causes in patients with NAFLD has stabilized over time, with cardio- and cerebral vascular disease (CVD) ranked first (35.6%), followed by extrahepatic malignancies (22.6%), infection (11.0%), kidney disease (7.5%), liver-related diseases (5.2%), respiratory diseases (3.9%), digestive diseases (3.5%), endocrine diseases (3.5%), and other diseases (7.2%). NAFLD patients had more deaths attributable to CVD, extrahepatic malignancies, liver-related diseases (all <jats:italic>P<\/jats:italic> &amp;lt; 0.001) and multiorgan failure than the deceased controls. The severity of steatosis was independently associated with these relationships (liver-related diseases: OR = 1.37, 95% CI: 1.20\u20131.59, cardio- and cerebrovascular diseases: OR = 1.23, 95% CI: 1.19\u20131.31, infectious diseases: OR = 1.14, 95% CI: 1.04\u20131.26, and renal diseases: OR = 1.21, 95% CI: 1.02\u20131.47, all <jats:italic>P<\/jats:italic> &amp;lt; 0.05) after adjustment for sex, body mass index (BMI), fasting blood glucose, low-density lipoprotein cholesterol, uric acid, metabolic syndromes and fibrosis index based on the 4 factors.<\/jats:p><jats:p><jats:bold>Conclusion<\/jats:bold> : NAFLD patients had higher proportions of death due to underlying CVD and liver-related diseases than the general population in China; these proportions positively correlated with steatosis degree.<\/jats:p>","DOI":"10.3389\/fmed.2020.584396","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T04:07:51Z","timestamp":1610510871000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Distinct Cause of Death Profiles of Hospitalized Non-alcoholic Fatty Liver Disease: A 10 Years' Cross-Sectional Multicenter Study in China"],"prefix":"10.3389","volume":"7","author":[{"given":"Yansong","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congxiang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzhao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bihui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/jgh.14813","article-title":"Non-alcoholic fatty liver disease in Asia: how is it different from the West?","volume":"34","author":"Wong","year":"2019","journal-title":"J Gastroenterol Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e027379","DOI":"10.1136\/bmjopen-2018-027379","article-title":"Fatty liver and mortality: a cohort population study in South Italy","volume":"9","author":"Caruso","year":"2019","journal-title":"BMJ Open."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1053\/j.gastro.2019.06.026","article-title":"Trends in mortality from extrahepatic complications in patients with chronic liver disease. from 2007 through 2017","volume":"157","author":"Kim","year":"2019","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12876-019-0972-6","article-title":"Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States","volume":"19","author":"Golabi","year":"2019","journal-title":"BMC Gastroenterol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e00011","DOI":"10.14309\/ctg.0000000000000011","article-title":"Impact of non-alcoholic fatty liver disease on cardiovascular outcomes in patients with stable coronary artery disease: a matched case-control study","volume":"10","author":"Liu","year":"2019","journal-title":"Clin Transl Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.jhep.2019.01.035","article-title":"The degree of hepatic steatosis associates with impaired cardiac and autonomic function","volume":"70","author":"Houghton","year":"2019","journal-title":"J Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.clinre.2019.02.004","article-title":"Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities","volume":"43","author":"\u00d6nnerhag","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pcad.2019.01.005","article-title":"Non-alcoholic fatty liver disease: prevalence and all-cause mortality according to sedentary behavior and cardiorespiratory fitness","volume":"62","author":"Croci","year":"2019","journal-title":"Prog Cardiovasc Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"16559","DOI":"10.1038\/s41598-018-34988-2","article-title":"Impact of non-alcoholic fatty liver disease on long-term cardiovascular events and death in chronic obstructive pulmonary disease","volume":"8","author":"Viglino","year":"2018","journal-title":"Sci Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/qjmed\/hcy227","article-title":"Non-alcoholic fatty liver disease and 30-day all-cause mortality in adult patients with community-acquired pneumonia","volume":"112","author":"Nseir","year":"2019","journal-title":"QJM."},{"key":"B11","first-page":"386","article-title":"Non-alcoholic fatty liver disease is associated with recurrent urinary tract infection in premenopausal women independent of metabolic syndrome","volume":"21","author":"Nseir","year":"2019","journal-title":"Isr Med Assoc J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e16018","DOI":"10.1097\/MD.0000000000016018","article-title":"The grade of nonalcoholic fatty liver disease is an independent risk factor for gallstone disease: an observational study","volume":"98","author":"Kim","year":"2019","journal-title":"Medicine."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.jhep.2019.08.018","article-title":"The risk of incident extrahepatic cancers is higher in nonalcoholic fatty liver disease than obesity - a longitudinal cohort study","volume":"71","author":"Allen","year":"2019","journal-title":"J Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/apt.14967","article-title":"Liver fat scores predict liver disease mortality in the United States population","volume":"48","author":"Unalp-Arida","year":"2018","journal-title":"Aliment Pharmacol Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.cgh.2019.07.013","article-title":"Long-term liver-related outcomes of patients with chronic liver diseases in Australia","volume":"18","author":"Huang","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of noninvasive tests for liver disease severity","volume":"43","author":"Musso","year":"2011","journal-title":"Ann Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"S209","DOI":"10.1016\/j.dsx.2016.12.033","article-title":"Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: a systematic review and meta-analysis","volume":"11","author":"Haddad","year":"2017","journal-title":"Diabetes Metab Syndr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/liv.14237","article-title":"Metabolic syndrome, but not non-alcoholic fatty liver disease, increases 10-year mortality: a prospective, community-cohort study","volume":"40","author":"Niriella","year":"2020","journal-title":"Liver Int."},{"key":"B20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study","volume":"155","author":"Vilar-Gomez","year":"2018","journal-title":"Gastroenterology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation task force on epidemiology and prevention; national heart, lung, and blood institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the study of obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation."},{"key":"B27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","article-title":"Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers","volume":"68","author":"Vilar-Gomez","year":"2018","journal-title":"J Hepatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1136\/gut.2011.242016","article-title":"Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease","volume":"60","author":"Wong","year":"2011","journal-title":"Gut."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/j.cgh.2019.08.003","article-title":"Increasing liver fat is associated with incident cardiovascular risk factors","volume":"18","author":"Brunner","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jceh.2019.02.005","article-title":"Screening of cardiovascular disease in nonalcoholic fatty liver disease: whom and how?","volume":"9","author":"Choudhary","year":"2019","journal-title":"J Clin Exp Hepatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/jgh.14856","article-title":"Nonalcoholic fatty liver disease and the incidence of myocardial infarction: a cohort study","volume":"35","author":"Sinn","year":"2020","journal-title":"J Gastroenterol Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"Schuppan","year":"2018","journal-title":"J Hepatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/nu9111218","article-title":"Dietary pattern during 1991-2011 and its association with cardio metabolic risks in Chinese adults: the china health and nutrition survey","volume":"9","author":"Li","year":"2017","journal-title":"Nutrients."},{"key":"B34","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nri3743","article-title":"Regulated cell death and inflammation: an auto-amplification loop causes organ failure","volume":"14","author":"Linkermann","year":"2014","journal-title":"Nat Rev Immunol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.584396\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T12:30:07Z","timestamp":1610541007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.584396\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":34,"alternative-id":["10.3389\/fmed.2020.584396"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.584396","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"article-number":"584396"}}